Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverse Event Reports Should Be 80% Electronic By Year End, FDA Hopes

Executive Summary

FDA hopes to receive 80% of adverse event reports in electronic format by the end of the year, CDER Division of Drug Risk Evaluation Associate Director Min Chen said

You may also be interested in...



FDA, EU Need Common Adverse Reaction Definitions, Lilly’s Simmons Says

FDA and European regulators should adopt a common definition for what adverse reactions must be reported, Lilly Global Product Safety Advisor Valerie Simmons, MD, said

FDA, EU Need Common Adverse Reaction Definitions, Lilly’s Simmons Says

FDA and European regulators should adopt a common definition for what adverse reactions must be reported, Lilly Global Product Safety Advisor Valerie Simmons, MD, said

Adverse Event Reporting Rule: FDA Seeks Comments On SNOMED Vs. MedDRA

FDA seeks comments on the use of SNOMED versus MedDRA terminology for suspected adverse event reporting

Related Content

UsernamePublicRestriction

Register

PS043154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel